Skip to main navigation Skip to search Skip to main content

Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.

  • SL Hands
  • , R Mason
  • , MU Sajjad
  • , Flaviano Giorgini
  • , A Wyttenbach

Research output: Contribution to Journal › Conference Article/Conference Proceedings › peer-review

Fingerprint

Dive into the research topics of 'Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease.'. Together they form a unique fingerprint.
Sort by

Keyphrases

Neuroscience